Individuals infected with the human immunodeficiency virus (HIV), the etiologic agent of acquired immunodeficiency syndrome (AIDS), often show symptoms associated with reactivation of Epstein-Barr virus (EBV). In this study, we show that exposure of EBV-positive B lymphocytes to HIV-I in vitro induc
Analysis of antigen uptake and presentation by Epstein-Barr virus-transformed human lymphoblastoid B cells
โ Scribed by Edward Chu; Dale Umetsu; Marianne Lareau; Evelyn Schneeberger; Raif S. Geha
- Publisher
- John Wiley and Sons
- Year
- 1984
- Tongue
- English
- Weight
- 1014 KB
- Volume
- 14
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
โฆ Synopsis
Analysis of antigen uptake and presentation by Epstein-Barr virus-transformed human lymphoblastoid B cells*
Epstein-Barr virus-transformed human B cells (EBV-B cells), but not resting B cells or B cells activated by T cell-derived factors, have been shown to support the proliferation of tetanus toxoid (=)-specific autologous T cell clones in response to 'IT antigen. The accessory cell function of EBV-B cells was compared to that of monocytes with regard to antigen uptake and processing.
After an 18-h incubation period with 1251-labeled lT, the amount of radioactivity associated with the cells (-50 ng/107 cells) and the percentage of cells containing radiolabeled material (-50%) were equivalent for EBV-B cells and monocytes. Like with monocytes, EBV-B cells pulsed with 'IT for 18 h or more were equivalent in their capacity to induce T cell proliferation to EBV-B cells to which soluble T I ' was added for the duration of the culture period. The requirements for antigen uptake and presentation to T cells were similar for both EBV-B cells and monocytes. Both processes were energy dependent, inhibited by cold (4"C), 2-deoxyglucose, and azide, and both required no de novo protein synthesis as they were not affected by pretreatment of the cells with the irreversible protein inhibitor pactamycin. Trypsin treatment of antigen-pulsed EBV-B cells and monocytes followed by fixation for 1 min in 0.03% paraformaldehyde completely abolished the capacity of both cell types to induce T cell proliferation.
In both EBV-B cells and monocytes, antigen presentation, but not antigen uptake, was inhibited by the addition of the lysosomotropic agent chloroquine during the antigen-pulse period suggesting that the mechanisms of antigen processing are similar for both cell types. Vacuoles positive for acid phosphatase with an electron microscopic structure similar to that of lysosomes were found in EBV-B cells but not in resting B cells or B cells activated by T cell-derived factors. The present observations indicate that EBV-B cells take up antigen and process it in a fashion similar to monocytes. The presence of lysosomes appears to correlate with the capacity of B cells to present antigen.
๐ SIMILAR VOLUMES
## Abstract Differential induction of EpsteinโBarr virus (EBV)โrelated antigens was observed after Sendai virusmediated fusion of producer and nonโproducer cells with various human and mouse cells. The EBVโdetermined early nuclear antigen (ENA), early antigen (EA) and viral capsid antigen (VCA) cou
## Abstract Lymphocytes adhere to cells or extracellular matrices to perform functions relating to cytotoxicity, extravasation and tissue localization, as well as modulation of lymphocyte growth and maturation. This adherence is mainly mediated by 3 families of cellโsurface adhesion molecules: inte
## Abstract The human lymphoblastoid cell line 6410 was superinfected with P3HRโ1 derived EpsteinโBarr virus. Subsequent to the first cycle of infection, characterized by early (EA) and virus capsid (VCA) antigen synthesis, the culture, designated 6410โEBV, continued to synthesize VCA. Further immu